White coat hypertension and left ventricle geometry in childhood

Serap Ata1, Duygu Övünç Hacıhamdioğlu2, Deniz Cihan3

  • 1Department of Pediatrics, Ümraniye Training and Research Hospital, Istanbul, Türkiye.

Blood Pressure
|December 18, 2025
PubMed

Insights

White-coat hypertension (WCH) is linked to abnormal heart geometry in normal-weight children, indicating an intermediate cardiovascular risk. This highlights the need for monitoring WCH in this population.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Health
  • Hypertension Research

Background:

  • White-coat hypertension (WCH) is a condition where blood pressure is elevated in a clinical setting but normal otherwise.
  • The relationship between WCH and cardiac structural changes, specifically left ventricular geometry, in children is not well-established.
  • Obesity is a known risk factor for cardiovascular disease, but the impact of WCH on cardiac geometry in both obese and normal-weight children requires investigation.

Purpose of the Study:

  • To investigate the association between white-coat hypertension (WCH) and left ventricular geometry abnormalities in children.
  • To compare the prevalence of abnormal left ventricular geometry in normal-weight and obese children with hypertension, WCH, and normotension.
  • To determine if WCH represents an intermediate cardiovascular risk state in pediatric populations.

Main Methods:

  • A retrospective, single-center study involving children categorized into obese and normal-weight groups.
  • Participants included children with hypertension, WCH, and normotensive controls.
  • Echocardiography and ambulatory blood pressure monitoring were used to assess cardiac structure and blood pressure patterns.

Main Results:

  • In normal-weight children, abnormal left ventricular geometry prevalence increased significantly with the severity of hypertension, from 1% in controls to 9.4% in WCH and 25.8% in hypertension.
  • In obese children, abnormal left ventricular geometry was prevalent across all groups (19.3% to 45.8%) but did not show a progressive increase with blood pressure phenotype severity.
  • The prevalence of abnormal left ventricular geometry was significantly higher in normal-weight children with WCH compared to controls.

Conclusions:

  • White-coat hypertension (WCH) is associated with abnormal left ventricular geometry in normal-weight children, suggesting it may be an intermediate cardiovascular risk marker.
  • The findings underscore the importance of identifying and monitoring WCH in normal-weight children for preventive cardiology.
  • Further research in larger, longitudinal cohorts is needed to elucidate the interaction between WCH and obesity on cardiovascular outcomes.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
354
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
358
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
361
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
447
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
370
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
186